Performance for Resection for Primary Lung Cancer Compared to STS and National Outcomes*
* These NIS data are the most recent data available at this time. There are more resection for primary lung cancer patients in a single year of NIS data than in the GTSD, so a decision was made to use 3 years of STS GTSD data.
Resection for Primary Lung Cancer Composite Measure Rating (July 2022 - June 2025)
| Overall Composite Score |
98.9%
(98.3 - 99.3)
|
98.9% (98.3, 99.3)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Operative Mortality |
99.3%
(98.7 - 99.7)
|
99.3% (98.7, 99.7)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Major Morbidity |
95.0%
(92.3 - 97.1)
|
95% (92.3, 97.1)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
Esophagectomy Composite Measure Rating (July 2022 - June 2025)
| Overall Composite Score |
96.0%
(93.3 - 98.0)
|
96% (93.3, 98)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Operative Mortality |
96.0%
(91.1 - 98.5)
|
96% (91.1, 98.5)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Major Morbidity |
86.3%
(76.9 - 93.3)
|
86.3% (76.9, 93.3)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
Better Than Expected
|
Resection for Primary Lung Cancer Overall Composite Score represents two domain scores in a single number:
- Absence of Operative Mortality: Proportion of primary lung cancer resection (i.e., wedge resection, segmentectomy, lobectomy, sleeve lobectomy, bilobectomy, pneumonectomy) patients [risk-adjusted] who do not experience operative mortality. Operative mortality is defined as hospital death, death within 30 days of surgery, or discharge to hospice.
- Absence of Major Morbidity: Proportion of primary lung cancer resection (i.e., wedge resection, segmentectomy, lobectomy, sleeve lobectomy, bilobectomy, pneumonectomy) patients [risk-adjusted] who do not experience any major morbidity. Major morbidity is defined as the presence of any of the following postoperative conditions: tracheostomy, respiratory failure/reintubation, initial ventilatory support>48 hours, ARDS, bronchopleural fistula, pulmonary embolus, pneumonia, unexpected return to OR, myocardial infarct.
Esophagectomy for Esophageal Cancer Composite Score represents two domain scores in a single number:
- Absence of Operative Mortality: Proportion of patients [risk-adjusted] who did not experience operative mortality. Operative mortality is defined as death during the same hospitalization as surgery, death within 30 days of surgery, or discharge to hospice.
- Absence of Major Morbidity: Proportion of patients [risk-adjusted] who did not experience any major complication. These are: 1) unexpected return to the operating room; 2) anastomotic leak requiring medical treatment only (Type 1 and Type 2); 3) respiratory failure/reintubation; 4) initial ventilator support >48 hours; 5) pneumonia; 6) new renal failure per RIFLE criteria; 7) recurrent laryngeal nerve paresis.
